AF Ablation Attracts Stronger Support In Updated Clinical Guidelines
This article was originally published in The Gray Sheet
Executive Summary
The growing use of catheter ablation to treat atrial fibrillation is supported by increasingly strong evidence, though the procedure should remain, for now, a second-line therapy to antiarrhythmic drugs, according to U.S. cardiology society guideline updates issued Dec. 20.
You may also be interested in...
AF Ablation: Surgery And Catheter Techniques Both Shine At AHA
Atrial fibrillation treatments involving standalone surgical ablation and catheter ablation were discussed in data presentations at the American Heart Association annual meeting last week.
News In Brief
Arctic Front moves in
HRS A-Fib Ablation Consensus Statement Offers Clinical Trial Advice
A new expert 1consensus statement on ablation of atrial fibrillation, created by a Heart Rhythm Society task force, includes 21 specific recommendations for the design and conduct of clinical trials of AF ablation devices